Bladder Cancer Market Growth, Size, Share, Industry Report and Forecast 2021-2027
The global
bladder cancer market is projected to grow at a considerable CAGR
of 5.2% during the forecast period. The main cause of bladder cancer includes
the consumption of tobacco products includes cigarettes, cigars, pipes, chewing
tobacco, and snuff. Moreover, extensive exposure to chemicals, past harmful
radiation exposure, and parasitic infections are other factors that
contributing to the growth of the market. Additionally, having a family history
of bladder cancer, having certain changes in the genes that are linked to
bladder cancer, and Past treatment with radiation therapy or certain anticancer
drugs, such as cyclophosphamide or ifosfamide. The increasing prevalence of
smoking and tobacco consumption has a major impact on the growth of the bladder
cancer market across the globe. Changing the lifestyle of people is a
significant cause of bladder cancer. Unhealthy eating activity is increasing
among people, which is a major risk for bladder cancer. As per the American
Lung Association, the average smoker smokes 15 cigarettes per day in the US.
Similar trends can be observed in other countries of Europe and China, and
Australia.
To Request a Sample of our Report on Bladder Cancer Market: https://www.omrglobal.com/request-sample/bladder-cancer-market
As per World Health
Organization (WHO), there are 1.1 billion people consume tobacco across the
globe. Smokers are 4 to 7 times more likely to develop bladder cancer than
non-smokers. Bladder cancer is the tenth most common cancer across the globe.
In 2018, there were 17 million new cases of bladder cancer across the globe. As
per Cancer Research UK, the incidence of cancer is estimated to reach 62%
during 2018-2040 across the globe. Bladder cancer is considered the fourth
common cancer in men whereas it is the least common cancer in women. As per the
American Cancer Society, there will be an estimated 80,470 new cases in the US
in 2019. Out of this, 61,700 new cases will be associated with male and 18,770
will be associated with the female. For instance, in March 2016 the National
Cancer Institute has invested $5.5 million in establishing laboratories to
advance research on biomarkers and biomarker assays for several cancers. Market
players can engage with these organizations so as expand their product
offerings in the coming years.
·
The market number available for – 2021-2027
·
Base year- 2020
·
Forecast period- 2021-2027
Segment Covered-
·
By Cancer type
·
By Diagnosis Method
·
By Therapy
Regions Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Key
questions addressed by the report
·
What is the market growth rate?
·
Which segment and region dominate the market in
the base year?
·
Which segment and region will project the
fastest growth in the market?
·
How COVID-19 impacted the market?
o Deviation from the
pre-COVID-19 forecast
o Most affected region and
segment
·
Who is the leader in the market?
·
How players are addressing challenges to sustain
growth?
·
Where is the investment opportunity?
A
full Report of Bladder Cancer Market is
Available at: https://www.omrglobal.com/industry-reports/bladder-cancer-market
·
Transitional Cell Bladder Cancer/ Urothelial
Carcinoma
·
Squamous Cell Bladder Cancer
·
Adenocarcinoma
·
Other Rare Types (Sarcomas, Carcinoma in Situ)
By
Diagnosis Method
·
Cystoscopy
·
Biopsy
·
Urinalysis
·
Urine Cytology
·
Intravenous Pyelogram (Ivp)
·
Other
By
Therapy
·
Chemotherapy
·
Immunotherapy
·
Radiation Therapy
·
Surgery
·
Other
Global
Bladder Cancer Market Report Segment by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
Rest of APAC
Rest of The World
·
Latin America
·
Middle East & Africa
Company Profile
·
AstraZeneca PLC
·
Bristol-Myers Squibb Co.
·
Celgene Corp.
·
Eli Lilly And Co.
·
Endo International Plc
·
Epocrates, Inc.
·
GlaxoSmithKline Plc
·
Hoffmann-La Roche Ltd.
·
Johnson & Johnson Services, Inc.
·
Merck & Co., Inc.
·
Merck KGaA
·
Novartis International AG
·
Nucleix Ltd.
·
Pfizer Inc.
·
Spectrum Pharmaceuticals, Inc.
Reasons for Buying from
us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More
Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/bladder-cancer-market
About Orion
Market Research
Orion Market Research (OMR) is a market
research and consulting company known for its crisp and concise reports. The
company is equipped with an experienced team of analysts and consultants. OMR
offers quality syndicated research reports, customized research reports, consulting
and other research-based services.
For More Information, Visit Orion
Market Research
Media Contact:
Company Name: Orion Market
Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
Comments
Post a Comment